Matches in DBpedia 2014 for { <http://dbpedia.org/resource/BMS-345541> ?p ?o. }
Showing items 1 to 34 of
34
with 100 items per page.
- BMS-345541 abstract "BMS-345541, marketed by Merck KGaA, is an anti-inflammatory, cell-permeable quinoxaline compound. It is an allosteric site-binding inhibitor with a primary target of IKK-2 and blocks the NF-κB-dependent transcription in mice.".
- BMS-345541 iupacName "4-(2′-Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline".
- BMS-345541 pubchem "9813758".
- BMS-345541 thumbnail BMS-345541.png?width=300.
- BMS-345541 wikiPageID "31724006".
- BMS-345541 wikiPageRevisionID "502549954".
- BMS-345541 c "14".
- BMS-345541 chembl "249697".
- BMS-345541 chemspiderid "7989508".
- BMS-345541 h "17".
- BMS-345541 hasPhotoCollection BMS-345541.
- BMS-345541 inchi "1".
- BMS-345541 inchikey "PSPFQEBFYXJZEV-UHFFFAOYAG".
- BMS-345541 iupacName "4".
- BMS-345541 molecularWeight "255.3".
- BMS-345541 n "5".
- BMS-345541 pubchem "9813758".
- BMS-345541 smiles "n1c3cccC".
- BMS-345541 stdinchi "1".
- BMS-345541 stdinchikey "PSPFQEBFYXJZEV-UHFFFAOYSA-N".
- BMS-345541 verifiedfields "changed".
- BMS-345541 verifiedrevid "458977224".
- BMS-345541 watchedfields "changed".
- BMS-345541 subject Category:Anti-inflammatory_agents.
- BMS-345541 type Drug.
- BMS-345541 type FunctionalSubstance.
- BMS-345541 comment "BMS-345541, marketed by Merck KGaA, is an anti-inflammatory, cell-permeable quinoxaline compound. It is an allosteric site-binding inhibitor with a primary target of IKK-2 and blocks the NF-κB-dependent transcription in mice.".
- BMS-345541 label "BMS-345541".
- BMS-345541 sameAs m.0gmg2jj.
- BMS-345541 sameAs Q4836000.
- BMS-345541 sameAs Q4836000.
- BMS-345541 wasDerivedFrom BMS-345541?oldid=502549954.
- BMS-345541 depiction BMS-345541.png.
- BMS-345541 isPrimaryTopicOf BMS-345541.
